Eyebiotech Limited

Active13503296 Private limited company
Incorporated
9 July 2021 (5 years)
Industry
Research and experimental development on biotechnology (72110)
Owned by
Merck & Co., Inc.
Accounts type
Full
Region
Greater London
Address
120 Moorgate
London
EC2M 6UR

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
22 July 2027
Last conf. stmt
8 July 2026

Officers 3 active

Officer details are public data from the Companies House register.

Officer history (10 former)
1 July 2026
Resigned Can Temucin, Ebru as Director
1 July 2026
Appointed O'Shaughnessy, Peter James as Director
11 July 2024
Resigned Davitian, Bernard Thomas as Director
11 July 2024
Appointed Can Temucin, Ebru as Director
11 July 2024
Appointed Rogers, Martin Ian as Director
11 July 2024
Appointed Lucas, Benjamin Paul as Director
11 July 2024
Resigned Adamis, Anthony Peter as Director
11 July 2024
11 July 2024
Resigned Harrison, Evelyn Melinda as Director
11 July 2024
Resigned Ross, Michael Jay as Director
11 July 2024
Resigned Akkaraju, Srinivas, Dr as Director
11 July 2024
Resigned Guyer, David R, Dr as Director
11 July 2024
Resigned Wallnofer, Andreas, Dr as Director
13 October 2023
Appointed Davitian, Bernard Thomas as Director
5 April 2022
Appointed Harrison, Evelyn Melinda as Director
3 February 2022
Appointed Wallnofer, Andreas, Dr as Director
3 February 2022
Appointed Akkaraju, Srinivas, Dr as Director
3 February 2022
Resigned Costine, James Allister John as Director
27 August 2021
Appointed Adamis, Anthony Peter as Director
2 August 2021
Appointed Guyer, David R, Dr as Director
2 August 2021
Appointed Ross, Michael Jay as Director
9 July 2021
Appointed Costine, James Allister John as Director
9 July 2021

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Merck & Co., Inc.
Corporate entity · Notified 11 July 2024
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporation
Reg. no. 7954610000
Former controllers (2)
13 October 2023
Ceased SV7 (Imf) GP LLP on Behalf of SV7 Impact Medicine Fund LP — Owns 25–50% of shares
3 February 2022
Ceased SV7 (Imf) GP LLP on Behalf of SV7 Impact Medicine Fund LP — Owns 75–100% of shares

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
16 January 2025Registered office address changed
26 January 2022Registered office address changed

Some other companies at this address

Other companies in this industry

By trade and location

New companies in London →

Explore the largest companies

Largest companies in London, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?